BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
68.25
-0.48 (-0.70%)
At close: Feb 21, 2025, 4:00 PM
67.75
-0.50 (-0.73%)
After-hours: Feb 21, 2025, 7:16 PM EST
BioMarin Pharmaceutical Revenue by Segment
History
| Date | Voxzogo | Vimizom | Naglazyme | Palynziq | Brineura | Aldurazyme | Kuvan | Royalty and Other | Roctavian |
|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 734.60M | 724.30M | 479.50M | 354.60M | 169.30M | 183.90M | 120.60M | 44.48M | 26.40M |
| Sep 30, 2024 | 672.30M | 705.00M | 467.80M | 342.40M | 164.90M | 187.60M | 129.30M | 45.90M | 18.10M |
| Jun 30, 2024 | 605.50M | 704.40M | 444.80M | 330.70M | 168.90M | 130.40M | 144.10M | 47.10M | 11.70M |
| Mar 31, 2024 | 534.90M | 701.10M | 402.90M | 317.30M | 161.70M | 132.10M | 166.10M | 47.80M | 4.30M |
| Dec 31, 2023 | 469.80M | 677.50M | 420.30M | 304.00M | 161.80M | 131.20M | 180.70M | 46.80M | 3.50M |
| Sep 30, 2023 | 390.90M | 674.10M | 422.50M | 288.50M | 160.80M | 126.20M | 197.60M | 45.70M | 800.00K |
| Jun 30, 2023 | 316.20M | 669.90M | 413.10M | 275.80M | 157.60M | 141.40M | 211.70M | 44.60M | - |
| Mar 31, 2023 | 237.30M | 663.80M | 438.80M | 262.50M | 157.20M | 138.40M | 218.70M | 50.10M | - |
| Dec 31, 2022 | 169.20M | 668.20M | 443.80M | 255.00M | 154.30M | 128.40M | 227.50M | 53.90M | - |
| Sep 30, 2022 | 108.10M | 649.40M | 426.40M | 246.50M | 149.10M | 110.90M | 242.40M | 56.50M | - |
| Jun 30, 2022 | 59.90M | 647.90M | 398.10M | 241.00M | 144.30M | 106.30M | 253.10M | 59.40M | - |
| Mar 31, 2022 | 25.50M | 623.10M | 401.10M | 238.30M | 136.90M | 97.10M | 274.30M | 58.30M | - |
| Dec 31, 2021 | 5.80M | 609.20M | 380.40M | 237.40M | 128.00M | 122.70M | 285.80M | 62.80M | - |
| Sep 30, 2021 | 100.00K | 620.40M | 417.00M | 223.20M | 125.60M | 103.70M | 306.40M | 63.30M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.